Arsenal Capital Partners is a progressive private equity firm that
facilitates transformational growth and change through a
collaborative approach.
IMDS (Innovative Medical Device Solutions) acquires Cencast Corporation
Logan, UT, January 26, 2009 - IMDS announced the completion of the acquisition of Cencast Corporation, a company based in Molalla, Oregon, that provides conventional and innovative precision metal casting solutions to the medical device industry. This acquisition further expands IMDS’ position as a premier outsourcing partner for medical device OEM’s.
“Cencast Corporation, as part of IMDS, will bring improved lead times to our customers who outsource products that are manufactured from castings,” stated Wade Fallin, President and CEO of...
Arsenal Capital To Acquire Ferro Corporation's Fine Chemicals Business
Renamed Novolyte Technologies, Arsenal Plans To Build A Global Energy Technology Company Around This Platform
NEW YORK, October 3, 2008 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare, and financial services companies, today announced that it has signed a definitive agreement to acquire Ferro Corporation’s (NYSE: FOE) Fine Chemicals business, a leading manufacturer of electrolytes used in the manufacture of lithium ion batteries, as well as high performance intermediates for other key end products, for $66 million.
The new stand-alone company will be named Novolyte...
Arsenal Capital Partners Invests in DG3
Partners with Management to Create Leading, Full-Service Global Graphic Communication Services Organization
NEW YORK, April 9, 2008 - Arsenal Capital Partners, a leading New York based private equity firm that invests in middle-market specialty industrial, healthcare and financial services companies, today announced that it has completed its acquisition of Diversified Global Graphics Group ("DG3").Arsenal and the company's management team, led by CEO Dr. Michael Cunningham, acquired DG3 in a proprietary transaction directly from Peter Furlonge the majority shareholder and former Chairman.
DG3 is a leading, global provider of commercial printing and graphic...
Arsenal Capital Partners Acquires Charter Brokerage
Partners with Management to Accelerate Growth of Leading Specialty Logistics Company
NEW YORK, February 21, 2008 - Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare and financial services companies, today announced that it has completed its acquisition of Charter Brokerage Holdings, LLC ("Charter"). Arsenal acquired Charter from Summit Park Partners and senior management.
Charter Brokerage Holdings is a premier non-asset based third party logistics ("3PL") provider to the North American petroleum and related industries. Charter's services include...
Arsenal Capital Partners Announces $30 Million Investment in FirstAgain
Investment in Innovative Online Consumer Lender with Experienced Management Team will Accelerate Growth
NEW YORK, February 13, 2008 - Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare and financial services companies, today announced that it has made a $30 million investment in FirstAgain, LLC, an online consumer lender focused on providing innovative loan products to individuals with excellent credit profiles.
San Diego-based FirstAgain offers the AnythingLoan, the nation's first completely paperless, consumer loan, which is unsecured and can be used for any purpose, including home...
Arsenal Capital Partners Establishes Shanghai Office
Presence in Mainland China Will Foster Growth Of Portfolio Companies; New Office Headed By Senior Operating Executive
NEW YORK, January 15, 2008 - Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare and financial services companies, today announced that it has established an office in Shanghai, China to provide its current and future portfolio companies with additional strategic insights, local and regional support, and expanded relationships in order to enhance opportunities for growth and productivity.
Arsenal has named Dr. Steve (XiaoHu) Li, formerly a senior executive with Arch Chemicals, Inc....